Phase II Trials in Heart Failure: The Role of Cardiovascular Imaging

American Heart Journal - United States
doi 10.1016/j.ahj.2011.03.031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Role of Galectin-3 in Heart Failure and Cardiovascular Disease

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2019English

The Future of Imaging in Cardiovascular Disease Intervention Trials

Current Opinion in Lipidology
NutritionGeneticsCell BiologyMolecular BiologyCardiologyEndocrinologyCardiovascular MedicineDieteticsMetabolismDiabetes
2016English

Heart Failure Clinical Trials - Broadening the Definition of the Ideal Heart Failure Site Investigator

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Cardiovascular Magnetic Resonance in the Evaluation of Heart Failure

Heart
Cardiovascular MedicineCardiology
2007English

Navigating the “MACE” in Cardiovascular Outcomes Trials and Decoding the Relevance of Atherosclerotic CVD Benefits Versus Heart Failure Benefits

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Imaging of Myocardial Oxidative Metabolism in Heart Failure

Current Cardiovascular Imaging Reports
Applied MicrobiologyBiotechnologyHistologyCell Biology
2013English

The Role of ANG II and Endothelin-1 in Exercise-Induced Diastolic Dysfunction in Heart Failure

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2001English

The Role of the Neurohormonal System in Heart Failure

Heart
Cardiovascular MedicineCardiology
1998English

The Role of Multimodality Cardiovascular Imaging in Peripartum Cardiomyopathy

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy